scholarly journals SS29. The Hemodynamic Impact of Balloon Angioplasty in Multiple Sclerosis Patients with Chronic Cerebrospinal Venous Insufficiency

2012 ◽  
Vol 55 (6) ◽  
pp. 85S
Author(s):  
Manish Mehta ◽  
R. Clement Darling ◽  
Sean P. Roddy ◽  
Paul B. Kreienberg ◽  
John B. Taggert ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Balloon Angioplasty ◽  
Venous Insufficiency ◽  
Chronic Cerebrospinal Venous Insufficiency ◽  
Multiple Sclerosis Patients

Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation

2013 ◽  
Vol 30 (1) ◽  
pp. 52-60 ◽  
Author(s):  
L Tromba ◽  
S Blasi ◽  
A Vestri ◽  
D Kiltzanidi ◽  
F Tartaglia ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Multivariate Analysis ◽  
Scale Score ◽  
Healthy Subjects ◽  
Venous Insufficiency ◽  
Disease Duration ◽  
Expanded Disability Status Scale ◽  
Chronic Cerebrospinal Venous Insufficiency ◽  
Disability Status ◽  
Multiple Sclerosis Patients

Objectives: To verify the prevalence of chronic cerebrospinal venous insufficiency in patients affected by different clinical forms of multiple sclerosis and in healthy subjects using the Zamboni ultrasound protocol combined with M-mode ultrasound examination. Materials and methods: We enrolled 112 patients with multiple sclerosis and 67 healthy subjects from 20 to 67 years of age. All the patients underwent Duplex and color-Doppler sonography of the neck vessels, transcranial colour duplex sonography, M-mode study of the valve system and of venous abnormalities. Subjects were positive for chronic cerebrospinal venous insufficiency when at least two of five hemodynamic criteria of the Zamboni protocol were fulfilled. Chronic cerebrospinal venous insufficiency condition was further analyzed by a multivariate analysis including age, sex, disease duration, subtypes of multiple sclerosis and expanded disability status scale score as independent variables. Results: No healthy subjects was positive for chronic cerebrospinal venous insufficiency, while in the sample of patients affected by multiple sclerosis the diagnosis was made in 59.8% of cases ( p < 0.0001). The first criterion was the most frequent in patients affected by multiple sclerosis and chronic cerebrospinal venous insufficiency (respectively 54.4% and 76.1%, p < 0.001). The second, third and fourth criteria were never present in healthy subjects but were detected in patients with multiple sclerosis. The positivity of the second criterion was associated with diagnosis of chronic cerebrospinal venous insufficiency in 100% of cases. The third criterion had a prevalence of 52.2% in the subgroup of chronic cerebrospinal venous insufficiency patients. It was positive in 36 multiple sclerosis patients and was associated with chronic cerebrospinal venous insufficiency diagnosis in all cases except one. The multivariate analysis showed that age, disease duration, sex, subtypes of multiple sclerosis and expanded disability status scale score were not considered predictors of this haemodynamic condition. Conclusion: Chronic cerebrospinal venous insufficiency is a haemodynamic condition strongly associated with multiple sclerosis and is not found in normal controls. The addition of M-mode ultrasound to the diagnostic protocol allows improved observation of venous valve abnormalities.

Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?

2010 ◽  
Vol 25 (6) ◽  
pp. 286-295 ◽  
Author(s):  
T Ludyga ◽  
M Kazibudzki ◽  
M Simka ◽  
M Hartel ◽  
M Świerad ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Endovascular Treatment ◽  
Balloon Angioplasty ◽  
Venous Insufficiency ◽  
Femoral Vein ◽  
Stent Migration ◽  
Vascular Pathology ◽  
Severe Bleeding ◽  
Technical Problems ◽  
Chronic Cerebrospinal Venous Insufficiency

Objectives The aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI). Although balloon angioplasty and stenting seem to be safe procedures, there are currently no data on the treatment of a large group of patients with this vascular pathology. Methods A total of 564 endovascular procedures (balloon angioplasty or, if this procedure failed, stenting) were performed during 344 interventions in 331 CCSVI patients with associated multiple sclerosis. Results Balloon angioplasty alone was performed in 192 cases (55.8%), whereas the stenting of at least one vein was required in the remaining 152 cases (44.2%). There were no major complications (severe bleeding, venous thrombosis, stent migration or injury to the nerves) related to the procedure, except for thrombotic occlusion of the stent in two cases (1.2% of stenting procedures) and surgical opening of femoral vein to remove angioplastic balloon in one case (0.3% of procedures). Minor complications included occasional technical problems (2.4% of procedures): difficulty removing the angioplastic balloon or problems with proper placement of stent, and other medical events (2.1% of procedures): local bleeding from the groin, minor gastrointestinal bleeding or cardiac arrhythmia. Conclusions The procedures appeared to be safe and well tolerated by the patients, regardless of the actual impact of the endovascular treatments for venous pathology on the clinical course of multiple sclerosis, which warrants long-term follow-up.

scholarly journals Retinal abnormalities in multiple sclerosis patients with associated chronic cerebrospinal venous insufficiency

2012 ◽  
Vol 1 (1) ◽  
Author(s):  
Aneta Adamczyk-Ludyga ◽  
Justyna Wróbeł ◽  
Marian Simka ◽  
Tomasz Ludyga ◽  
Paweł Latacz ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Venous Insufficiency ◽  
Chronic Cerebrospinal Venous Insufficiency ◽  
Multiple Sclerosis Patients

scholarly journals An overview of randomized controlled trials on endovascular treatment for chronic cerebrospinal venous insufficiency in multiple sclerosis patients

Phlebologie ◽  
2020 ◽  
Author(s):  
Marian Simka
Keyword(s):  
Multiple Sclerosis ◽  
Endovascular Treatment ◽  
Clinical Efficacy ◽  
Venous Insufficiency ◽  
Randomized Clinical Trials ◽  
Early Stage ◽  
Safe Procedure ◽  
Chronic Cerebrospinal Venous Insufficiency ◽  
Multiple Sclerosis Patients ◽  
Venous Angioplasty

AbstractAbout ten years ago it was hoped that venous angioplasty for abnormal veins, primarily the internal jugular veins, will be a much awaited treatment for multiple sclerosis. Yet, a majority of randomized clinical trials on endovascular treatment for chronic cerebrospinal venous insufficiency did not reveal clinical efficacy of these procedures in multiple sclerosis patients. Still, a detailed analysis of these trials suggests that they were poorly designed, underpowered and endovascular techniques used were often far from being optimal. Nonetheless, even considering weak points of these trials, it can be concluded that venous angioplasty should not be used as a routine treatment modality in multiple sclerosis patients. Still, a possibility that some patients may benefit from endovascular treatment cannot be ruled out. This may concern patients at early stage of the disease and presenting with lesions that can easily be managed with balloon angioplasty. Therefore, we need more studies evaluating clinical efficacy of venous angioplasty in selected subgroups of multiple sclerosis patients. Importantly, it has already been demonstrated that venous angioplasty in multiple sclerosis patients is a safe procedure. Thus, also from an ethical point of view, such trials seem justifiable.

Sign in / Sign up

Export Citation Format

Share Document